Application | Comment | Organism |
---|---|---|
drug development | because the L-arginine pathway is essential for Giardia lamblia survival and absent in high eukaryotes including humans, the enzyme is a potential target for drug development | Giardia intestinalis |
Cloned (Comment) | Organism |
---|---|
gene cbk, recombinant expression in Escherichia coli strain BL21(DE3)Star as a TEV protease-cleavable, His-tagged, maltose binding protein fusion protein | Giardia intestinalis |
Crystallization (Comment) | Organism |
---|---|
purified detagged recombinant enzyme in complex with nonhydrolyzable ATP analogue, adenosine 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-PNP), and with citric acid, hanging drop vapor diffusion method, mixing of 30 mg/ml protein in 50 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 5 mM MgCl2, and 1 mM DTT, with an equal volume of mother liquor containing 0.4 M ammonium citrate dibasic, pH 5.0, and 21% w/v PEG 3350, soaking of crystals in 50 mM AMP-PNP, X-ray diffraction structure determination and analysis at 2.1-2.6 A resolution | Giardia intestinalis |
General Stability | Organism |
---|---|
DTT is required to prevent the protein from aggregation | Giardia intestinalis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Giardia intestinalis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + NH3 + CO2 | Giardia intestinalis | - |
ADP + carbamoyl phosphate | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Giardia intestinalis | O97438 | gene cbk | - |
no activity in Homo sapiens | - |
- |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
ATP + NH3 + hydrogencarbonate = ADP + carbamoyl phosphate + H2O | the protein residues involved in ligand binding, together with a model of the transition state, suggest that catalysis follows an in-line, predominantly dissociative, phosphotransfer reaction mechanism, and that closure of the flexible auxiliary domain is required to protect the transition state from bulk solvent. Model of the transition state, overview | Giardia intestinalis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + NH3 + CO2 | - |
Giardia intestinalis | ADP + carbamoyl phosphate | - |
r | |
additional information | ligand binding involves conformational flexibility of an auxiliary domain (amino acid residues 123-170), which exhibits open or closed conformations or structural disorder, depending on the bound ligand | Giardia intestinalis | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | the enzyme structure shows a core alpha/beta domain. A region comprising 30 amino acid residues flanking the active site is largely disordered in the crystal and has a possible role for enzyme conformational transition during catalysis | Giardia intestinalis |
Synonyms | Comment | Organism |
---|---|---|
Cbk | - |
Giardia intestinalis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ADP | - |
Giardia intestinalis | |
ATP | - |
Giardia intestinalis | |
additional information | nucleotide binding structure and conformational flexibility analysis, overview | Giardia intestinalis |
General Information | Comment | Organism |
---|---|---|
metabolism | carbamate kinase catalyzes the last step of the essential L-arginine pathway, converting ADP and carbamoyl phosphate to ATP and ammonium carbamate | Giardia intestinalis |